tbuckley/cabot-search huggingface dataset:
Multi-Cancer Early Detection Test Is Sensitive and Accurate in Detecting Shared DNA Methylation Signal in a Variety of Lymphoid and Plasma Cell Neoplasms
Authors: Candace Westgate, Gilles Salles, Stephannie Shih, Margarita Lopatin, Kathryn N. Kurtzman, Katerina Kappes, Oliver Venn, Samir Parekh, Jeffrey M. Venstrom, Anas Younes, Rita Shaknovich
Journal: Blood (2023)
Age-Adapted Chemotherapy for Adults &amp;gt;40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes
Authors: Marc Schwartz, Jonathan A Gutman, Christine M. McMahon, Maria L Amaya, Daniel A. Pollyea, Matthew Witkowski, Mohd Minhajuddin, Clayton Smith, Craig T. Jordan
Journal: Blood (2023)
Expression of Cell Surface Immunotherapy Targets across the Multiple Myeloma Disease Spectrum: Implications for Sequencing and Multi-Target Strategies
Authors: Ciara Louise L. Freeman, Meghan Menges, Jerald Noble, Raghunandan Reddy Alugubelli, Rafael Renatino-Canevarolo, Oliver Hampton, Praneeth Reddy Sudalagunta, Salvatore Corallo, Ariosto Siqueira Silva, Mark B Meads, Rachid Baz, Melissa Alsina, Doris K. Hansen, Taiga Nishihori, Omar Castaneda, Brandon Blue, Ariel F. Grajales-Cruz, Yunfei Wang, Patrick Hwu, John Koomen, Kenneth H. Shain, Frederick L. Locke
Journal: Blood (2023)
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS): A Review of Pharmacovigilance
Authors: Ugochi Ebinama, Rishab Prakash, Paolo Strati, Sairah Ahmed, Sherry Adkins, Samer A. Srour, Michael L. Wang, Preetesh Jain, Elizabeth J. Shpall, Anath Lionel, Meng Lui, Sattva S. Neelapu, Krina K. Patel, Swami P. Iyer
Journal: Blood (2023)
A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial
Authors: Huiying Qiu, Qiaomei He, Xi Sun, Ying Wang, Jiahua Niu, Jun Yang, Chongmei Huang, Kun Zhou, Yin Tong, Yu Cai, Baoxia Dong, Liping Wan, Xianmin Song
Journal: Blood (2023)
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Authors: Chris J Packard, Angela Pirillo, Sotirios Tsimikas, Brian A Ference, Alberico L Catapano
Journal: Cardiovascular Research (2023)

The availability of pharmacological approaches able to effectively reduce circulating LDL cholesterol (LDL-C) has led to a substantial reduction in the risk of atherosclerosis-related cardiovascular disease (CVD). However, a residual cardiovascular (CV) risk persists in treated individuals with optimal levels of LDL-C. Additional risk factors beyond LDL-C are involved, and among these, elevated levels of triglycerides (TGs) and TG-rich lipoproteins are causally associated with an increased CV risk. Apolipoprotein C-III (apoC-III) is a key regulator of TG metabolism and hence circulating levels through several mechanisms including the inhibition of lipoprotein lipase activity and alterations in the affinity of apoC-III-containing lipoproteins for both the hepatic receptors involved in their removal and extracellular matrix in the arterial wall. Genetic studies have clarified the role of apoC-III in humans, establishing a causal link with CVD and showing that loss-of-function mutations in the APOC3 gene are associated with reduced TG levels and reduced risk of coronary heart disease. Currently available hypolipidaemic drugs can reduce TG levels, although to a limited extent. Substantial reductions in TG levels can be obtained with new drugs that target specifically apoC-III; these include two antisense oligonucleotides, one small interfering RNA and an antibody.
Longitudinal Analysis of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL) Using KAPA HyperCap Design Share Non-Hodgkin Lymphoma (KAPA HyperCap DS NHL) Next-Generation Sequencing (NGS) Panel
Authors: Vladislava Melnikova, Clara Bermejo, Richard Chien, Parul Agarwal, Alexandra Markus, Bowdoin Su, Renee Stokowski, Ronald McCord, Alex F. Herrera, Laurie H. Sehn
Journal: Blood (2023)
Early-Stage Follicular Lymphoma: Learnings from the Final Analysis of the Multicenter Phase II FIL (Fondazione Italiana Linfomi) “Miro” Trial, Combining Local Radiotherapy and MRD-Driven Immunotherapy
Authors: Alessandro Pulsoni, Maria Elena Tosti, Simone Ferrero, Stefano Luminari, Alessandra Dondi, Anna Marina Liberati, Natalia Cenfra, Daniela Renzi, Manuela Zanni, Carola Boccomini, Andrés José María Ferreri, Sara Rattotti, Vittorio Ruggero Zilioli, Patrizia Bernuzzi, Silvia Bolis, Gerardo Musuraca, Luca Nassi, Tommasina Perrone, Caterina Stelitano, Antonella Anastasia, Paolo Corradini, Giovanni Partesotti, Francesca Re, Emanuele Cencini, Clara Mannarella, Donato Mannina, Anna Lia Molinari, Monica Tani, Giorgia Annechini, Giovanni Manfredi Assanto, Lavinia Grapulin, Anna Guarini, Marzia Cavalli, Lucia Anna De Novi, Riccardo Bomben, Elena Ciabatti, Barbara Mantoan, Daniela Drandi, Irene Della Starza, Luca Arcaini, Umberto Ricardi, Valter Gattei, Sara Galimberti, Marco Ladetto, Robin Foà, Ilaria Del Giudice
Journal: Blood (2023)
Trial-in-Progress: A Phase 1/2 Multi-Center Study of Onct-808, a ROR1-Specific CAR T, in Adult Patients with Relapsed/Refractory Aggressive B Cell Lymphoma
Authors: Michael L. Wang, Matthew J. Frigault, Salim Yazji, Yisrael Katz, James Robinson, James B. Breitmeyer, Matthew G. Mei, Caron A Jacobson
Journal: Blood (2023)
Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective Cohort Study
Authors: Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Wenjun Wu, Yi Zhao, Yi Li, Zhen Cai
Journal: Blood (2023)
Insight into the Natural History of Hereditary Thrombotic Thrombocytopenic Purpura: Short- and Long-Term Outcomes in a Longitudinally Followed Large Patient Cohort of the International Hereditary TTP Registry
Authors: Marissa Schraner, Erika Tarasco, Odile Stalder, Kenneth D. Friedman, James N. George, Ingrid Hrachovinova, Paul N. Knöbl, Masanori Matsumoto, Reinhard Schneppenheim, Anne-Sophie Von Krogh, Zuzana Cermakova, Magdalena Górska-Kosicka, Kazuya Sakai, György Sinkovits, Yasmine El Chazli, Carlo R. Largiadèr, Oleg Pikovsky, Jerzy Windyga, Bernhard Lämmle, Johanna A. Kremer Hovinga
Journal: Blood (2023)
Safety, Efficacy and T-Cell Predictive Biomarkers in a Phase I Trial of Copanlisib+Nivolumab in Patients with Richter's Transformation (RT) or Transformed Non-Hodgkin Lymphoma (tNHL)
Authors: Geoffrey P. Shouse, Leslie L. Popplewell, Alex Muir, Tanya Siddiqi, Alex F. Herrera, Olga Danilova, Sandrine Puverel, Lili Wang, Adam S Kittai, Lu Chen, Matthew S Davids, Alexey Danilov
Journal: Blood (2023)
<i>E</i>valuating the <i>S</i>afety of HCAR19 (Now Actalycabtagene Autoleucel- Actaly-Cel™), a Novel <i>H</i>umanized CD19-Directed Chimeric Antigen Receptor T-Cells in Pediatric, Adolescents, and Young Adults with Relapsed/ Refractory B- Acute Lymphoblastic Leukemia (ESHA) - Report of Phase-1B
Authors: Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, Chetan Dhamne, Prashant Tembhare, Papagudi Ganesan Subramanian, Nikhil Patkar, Minal Poojary, Albeena Nisar, Deepali Pandit, Khushali Pandit, Atharva Karulkar, Ankesh Kumar Jaiswal, Aalia Khan, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik, Nirmalya Roy Moulik, Shyam Srinivasan, Shilpushp Bhosle, Sumathi Hiregoudar, Shashank Ojha, Lingaraj Nayak, Jayshree Thorat, Bhausaheb Bagal, Manju Sengar, Nishant Jindal, Akanksha Chichra, Sumeet Mirgh, Anant Gokarn, Sachin Punatar, Sunil Rajadhyaksha, Navin Khattry, Shripad Banavali, Steven Highfill, Nirali N. Shah, Rahul Purwar
Journal: Blood (2023)
<i>Trp53</i>-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a <i>Jak2</i> V617F-Driven Myeloproliferative Neoplasms Mouse Model
Authors: Ranran Zhang, Yashaswini Janardhanan, Rohit Haldar, Leanne Cooper, Sebastien Jaquelin, Jasmin Straube, Megan Bywater, Steven W Lane
Journal: Blood (2023)
Impact of Premedication Prior to Platelet Transfusion on Platelet Increment Among Hemato-Oncological Patients
Authors: Tamar Berger, Vered Yahalom, Odil Giladi, Eithan Kugler, Tzippy Shochat, Victoria Meirman, Ella Gal, Tetyana Klebovsky, Ofir Wolach, Moshe Yeshurun, Pia Raanani, Liat Shargian, Oren Pasvolsky
Journal: Blood (2023)
Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease
Authors: Ana Boban, Robert F Sidonio, Leonid Dubey, Kateryna V Vilchevska, Adlette Inati, Claudia Djambas Khayat
Journal: Blood (2023)
Is the Youngest Donor Always the Best Choice to Optimize Outcomes for Matched Unrelated Allogeneic Transplant? Improving Precision Using Novel Statistical Methodology
Authors: Rodney A. Sparapani, Martin J. Maiers, Stephen R. Spellman, Bronwen E. Shaw, Purushottam W. Laud, Steven M. Devine, Caitrin Bupp, Meilun He, Brent R. Logan
Journal: Blood (2023)
Long-Term Outcome of a Unique Haploidentical High-Dose Peripheral Stem Cell Transplantation Protocol for Hematologic Malignancies: A Prospective Single-Center Study
Authors: Ming Jiang, Hailong Yuan, Jianli Xu, Jianhua Qu, Gang Chen, Nannan Pang, Hongbo Wang, Kaile Zhang, Linglu Ding, Xiaojuan Bi, Wenyan Miao, Le Zhang
Journal: Blood (2023)
Facility-Related Healthcare Resource Utilization (HCRU) for Patients Treated with Idecabtagene Vicleucel (Ide-Cel, bb2121) in a Real-World (RW) Setting: A Single-Center Experience
Authors: Lauren C. Peres, Pallavi Patwardhan, David Huggar, Gabriel De Avila, Laura B. Oswald, Ariel F. Grajales-Cruz, Brandon Blue, Julieta Abraham Miranda, Kayla Reid, Hien Liu, Taiga Nishihori, Kenneth H. Shain, Rachid Baz, Melissa Alsina, Omar Castaneda, Frederick L. Locke, Ciara Louise L. Freeman, Simrandeep Tiwana, Afraim Botros, Doris K. Hansen
Journal: Blood (2023)
Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ronda Lun, Amin Zharai, Ranjeeta Mallick, Dylan Burger, Gabriele Zitikyte, Steven Hawken, Philip Stephen Wells
Journal: Blood (2023)
Transposable Elements Are Differentially Expressed in MDS Stem Cells in a Disease-Stage-Specific Manner
Authors: Shuhei Kurosawa, Motohiko Oshima, Yaeko Nakajima-Takagi, Naoya Takayama, Daisuke Shinoda, Satoshi Kaito, Takahiro Kamiya, Yuta Yamada, Shohei Andoh, Kensuke Kayamori, Emiko Sakaida, Eriko Sato, Nozomi Yusa, Kazuaki Yokoyama, Yasuhito Nannya, Arinobu Tojo, Seiya Imoto, Bahityar Rahmutulla, Atsushi Kaneda, Kiyoshi Yamaguchi, Yoichi Furukawa, Noriko Doki, Kei Nishikawa, Ye Ding, Tomohiro Myojo, Yuka Harada, Hironori Harada, Atsushi Iwama
Journal: Blood (2023)
Prime Editing Efficiently and Precisely Corrects Causative Mutation in Chronic Granulomatous Disease, Restoring Myeloid Function: Toward Development of a Prime Edited Autologous Hematopoietic Stem Cell Therapy
Authors: Jack M Heath, Jacob Stuart Orenstein, Justin G Tedeschi, Allen Ng, Maria D Collier, Julia Kushakji, Alan J Wilhelm, Andrew Taylor, David P Waterman, Suk See De Ravin, Harry L Malech, Andrew V Anzalone, Jeremy S Duffield, Jennifer L Gori
Journal: Blood (2023)
Individualized Dosing of Ropeginterferon Alfa-2b Ensures Optimal Response in Patients with Low-Risk Polycythemia Vera (PV)
Authors: Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Liliya Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian
Journal: Blood (2023)
AsCas12a Gene Editing of <i>HBG1/2</i> Promoters with EDIT-301 Results in Rapid and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia
Authors: Rabi Hanna, Haydar Frangoul, Christopher McKinney, Luis Pineiro, Markus Mapara, Jignesh Dalal, Kai-Hsin Chang, Michael Jaskolka, Keunpyo Kim, Daphne L. Farrington, Maha Wally, Baisong Mei, Adebayo Lawal, Olubunmi O. Afonja, Mark C. Walters
Journal: Blood (2023)
Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly U.S. Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting
Authors: Beenish S Manzoor, Scott F. Huntington, Dureshahwar Jawaid, Justin T. Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Jalpa A. Doshi
Journal: Blood (2023)
Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral Blood
Authors: Xiangjun Zeng, Jimei Ge, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao
Journal: Blood (2023)
Development of a Same-Day Closed CAR-T Cell Manufacturing Process to Generate Lentivector Loaded Lymphocytes Ready for Subcutaneous Injection
Authors: Sid Kerkar, Lintao Liu, Michael Betts, Liang Li, Michelle Andraza, Ewa Jaruga-Killeen, Cody Gowan, Ting Han, Jia Shi, Rang Gao, Suraj Kachgal, Gregory Wade, Wei Zhang, Gregory Frost
Journal: Blood (2023)
Deregulation of HLA-Class I and Class II Genes in Chip, MDS, and Acute Leukemia and Similarity between Chip and MDS in HLA Profile
Authors: Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, James McCloskey, Katherine Linder, Jeffrey Justin Estella, Jamie Koprivnikar, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy
Journal: Blood (2023)
Non-Interventional Observational Analysis of the Clinical Outcomes with IO-FIVE (Immune-Oncology Fast In Vivo Efficacy Test) in Lymphoma Patients
Authors: Chanjuan Jin, Bin Xie, Di Zhou, Yanan Zhao, Wei Hua, Zhenle Bi, Yang Liu, Kaimeng Hu, Lintao Bi, Danyi Wen
Journal: Blood (2023)
Polygenic HLA-Class I and HLA-Class II Models Define Various Types of Lymphoma
Authors: Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy
Journal: Blood (2023)
Predicting Clonal Evolution to Secondary Myeloid Neoplasms in Aplastic Anemia through Machine Learning
Authors: Ahmet Celal Toprak, Taha Bat, Mutlu Mete, Carmelo Gurnari, Zoe Bass, Jaroslaw P. Maciejewski, Hussein Awada, Alper Olcal, Ibrahim F. Ibrahim
Journal: Blood (2023)
Acute Leukemia and MDS Patients Older Than 70 Years Have Inferior Survival Following Allogeneic Stem Cell Transplant Compared to Those with 60-69 Years of Age
Authors: Asmita Shukla, Seongho Kim, Hyejeong Jang, Andrew Kin, Aasiya Matin, Lois Ayash, Abhinav Deol, Voravit Ratanatharathorn, Joseph Uberti, Dipenkumar Modi
Journal: Blood (2023)
Soluble PD-L1 Predicts Poor Outcome and Disease Progression in Patients with <i>De Novo</i> Myelodysplastic Syndromes
Authors: Xingcheng Yang, Xiaoying Zhang, Juan Peng, Lifang Huang, Shaolong He, Zhiqiong Wang, Liting Chen, Chunrui Li, Ling Ma, Jia Wei
Journal: Blood (2023)
Venous Thromboembolism in Hematopoietic Stem Cell Transplantation
Authors: Jodi Chiu, Brianna Ananthan, Matthew Lawrence, Mohamed Aly, Dhuvaraha Srikrishnaraj, Madeleine Weichel, Uday Deotare, Anargyros Xenocostas, Alejandro Lazo-Langner
Journal: Blood (2023)
Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study
Authors: Elisa Albi, Lydia Scarfo, Silvia Heltai, Eloise Scarano, Luana Schiattone, Lucia Farina, Riccardo Moia, Marina Deodato, Andrea Ferrario, Marina Motta, Alessandro Noto, Rosaria Sancetta, Marta Coscia, Paolo Rivela, Luca Laurenti, Marzia Varettoni, Eleonora Perotta, Antonella Capasso, Pamela Ranghetti, Francesca Martini, Emanuela Sant'Antonio, Catalina Combi, Maria Colia, Paolo Ghia
Journal: Blood (2023)
Non-O Blood Group and Pretreatment Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
Authors: Vladimir Otasevic, Jelena Ivanovic, Vojin Vukovic, Natasa Milic, Sofija Kozarac, Andrej Pesic, Biljana Mihaljevic, Jawed Fareed, Darko Antic
Journal: Blood (2023)
3Ts Score, an Attempt for Less Testing in Thrombocytopenia Patients with Suspected Heparin Induced Thrombocytopenia (HIT): Retrospective Analysis in a University Hospital Setting
Authors: Mahmoud Abdallah, Leena Alhusari, Khurram Anwar, Ihab Tahboub, Kemnasom Nwanwene, Moh'd Masoudi, Love Kumar
Journal: Blood (2023)
Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis
Authors: Lydian A. de Ligt, Aafke E. Gaartman, Kadère Konté, Taco W. Kuijpers, Karin Fijnvandraat, Bart J. Biemond, Robin van Bruggen, Erfan Nur
Journal: Blood (2023)
The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center
Authors: Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang
Journal: Blood (2023)
Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration
Authors: Zijun Y. Xu-Monette, Li Yu, Cancan Luo, Yong Li, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Xiangshan Fan, Xiaosheng Fang, Karen Dybkaer, Ali Sakhdari, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, F. B. Hagemeister, Dennis O'Malley, Qingyan Au, Harry Nunns, Heounjeong Go, Maurilio Ponzoni, Andrés José María Ferreri, Michael Møller, Benjamin M. Parsons, Joannes H.J.M. Van Krieken, Miguel Piris, Jane Winter, Bing Xu, Mingzhi Zhang, Ken H. Young
Journal: Blood (2023)
Multi-Center Clinical Validation of a Mass Spectrometry Immunoassay for the Diagnosis and Monitoring of Multiple Myeloma and Associated Disorders
Authors: Oscar Berlanga, Jane Birtwistle, Syreeta Allen, Gemma Malin, Cristina Simion, Habib El-Khoury, Julia Colchie, Luca Bertamini, Grace Fleming, Erica M. Horowitz, Irene M. Ghobrial, Kaleb B McLendon, John Roback, Andrew S Neish, Sarah K Grewal, Gabriella Lakos
Journal: Blood (2023)
Initial Clinical Results and Immune Correlates of a Phase 2 Study of Daratumumab, Bortezomib, Dexamethasone Followed By a Proteasome Inhibitor <i>in</i>-Class Transition ( <i>i</i>CT) to Daratumumab, Ixazomib, Dexamethasone in Relapsed Refractory Multiple Myeloma
Authors: Hans C. Lee, June Li, Heather Lin, Astrid D. Murga, Gabriela M Rodriguez, Mostafa E. Mohamed, Jared Henderson, Sarah Rodriguez, Melody R. Becnel, Donna M. Weber, Swami P. Iyer, Gregory P. Kaufman, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Stephen J. Noga, Michael R. Green, Robert Z. Orlowski, Cara L Haymaker
Journal: Blood (2023)
Cladribine and Cyclophosphamide Lymphodepletion Prior to Brexucabtagene Autoleucel in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma
Authors: Filip Ionescu, Rawan Faramand, Hanna Bailey, Christina A Bachmeier, Elizabeth DiMaggio, Turab Mohammed, Leidy Lismeris Isenalumhe, Frederick L. Locke, Michael D. Jain, Bijal D. Shah
Journal: Blood (2023)
Poly(ADP-Ribose) Glycohydrolase (PARG) Removes Repressive Poly-ADP Ribose Marks from DNA Polymerase Theta (PolΘ) to Stimulate DNA Double-Strand Breaks Repair in Myeloid Malignancies
Authors: Umeshkumar Vekariya, Leonid Minakhin, Mrityunjay Tyagi, Tatiana Kent, Gurushankar Chandramouly, Katherine Sullivan-Reed, Jessica Atkins, Margaret Nieborowska-Skorska, Anna-Mariya Kukuyan, Richard Pomerantz, Tomasz Skorski
Journal: Blood (2023)
Recombinant Human Erythropoietin Combined with All-Trans Retinoic Acid and Testosterone Undecanoate in the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndromes: Updated Results of a Multicenter, Single-Arm, Prospective Trial
Authors: Chen Mei, Yaping Xie, Yanping Shao, Zheng Ge, Hongyan Tong
Journal: Blood (2023)
Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program
Authors: Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Journal: Blood (2023)
Unraveling the Link: Cannabis Use Disorder and Pulmonary Embolism-Related Hospital Outcomes in Female Breast Cancer Survivors
Authors: Sai Gautham Kanagala, Nitin Ghadge, Nishanth Katukuri, Alpha James, Avinash Kadiyala, Sai Diksha Vutukuru, Borzoo Tajdin, Akhila Nalla, Devi Meghana Kotharu, Charan Thej Reddy Vegivinti, Praneeth Reddy Keesari, Akhil Jain, Rupak Desai
Journal: Blood (2023)
Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH
Authors: Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia MC Langemeijer, Satheesh Chonat, Jia Cao, Vincent Chow, Haby Henary
Journal: Blood (2023)
Effectiveness and Safety of Rabbit Anti-Thymocyte Globulin Versus Non-Anti-Thymocyte Globulin Regimens for Graft-Versus-Host Disease Prophylaxis: A Systematic Review and Meta-Analysis
Authors: Jaap Jan Boelens, Andrew Bodiford, Francois Bourhis, Marie Baccara-Dinet, Lauren Rota, Michaela Lysikova
Journal: Blood (2023)
Second Vs Third Line Treatment with Axicabtagene Ciloleucel for Large B Cell Lymphoma - a Real-Life National Multicenter Retrospective Cohort Study with Propensity Score Matching
Authors: Gil Fridberg, Odelia Amit, Liat Shargian, Ofrat Beyar Katz, Sigal Grisariu, Chava Perry, Ronit Gurion, Batia Avni, Tsila Zuckerman, Irit Avivi Mazza, Ron Ram
Journal: Blood (2023)
Efficacy and Safety of Golcadomide, a Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, Combined with Rituximab in a Phase 1/2 Open-Label Study of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: Julio C. Chavez, Loretta J. Nastoupil, Franck Morschhauser, Guillaume Cartron, Judit Mészáros Joergensen, Emmanuel Bachy, Pierre Bories, Victoria Campbell, Bijou Fontanet, Poliana P. Patah, Bérengère de Moucheron, Soraya Carrancio, Xirong Zheng, Chaoqun Mei, Michael Pourdehnad, Jean-Marie Michot
Journal: Blood (2023)
Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Authors: Chika Kato, Yuho Najima, Daichi Sadato, Chizuko Hirama, Kana Kato, Kaori Kondo, Yasutaka Sadaga, Satoshi Sakai, Yasuhiro Kambara, Yoshimi Nabe, Ko Teshima, Kazuya Asano, Kazuya Kurihara, Atsushi Jinguji, Masashi Shimabukuro, Fumihiko Ouchi, Kazuki Inai, Satoshi Koi, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Kyoko Haraguchi, Takeshi Kobayashi, Hironori Harada, Yoshiki Okuyama, Yuka Harada, Noriko Doki
Journal: Blood (2023)
Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia
Authors: Jesus Duque Afonso, Veratti Pia, Usama-Ur Rehman, Heike Herzog, Jan Mitschke, Gabriele Greve, Julian Eble, Bettina Berberich, Johanna Thomas, Milena Pantic, Miguel Waterhouse, Gaia Gentile, Olaf Heidenreich, Cornelius Miething, Michael Lübbert
Journal: Blood (2023)
Persistent Albuminuria and Chronic Kidney Disease in Adults with Sickle Cell Disease: Results from a Multicenter Natural History Study
Authors: Vimal K. Derebail, Laura Y. Zhou, Yihan Tang, Laila Elsherif, Kammie L. Patillo, David Wichlan, Kristina Landes, Paula McCune, Laura R. Loehr, Payal Desai, Robert Cronin, Jianwen Cai, Kenneth I. Ataga
Journal: Blood (2023)
Heme Attenuates T Cell Exhaustion and Drives Effector Function: Implications for Immune and Adoptive T Cell Therapy
Authors: Pulkit Gupta, Heather Lin, Remya Nair, Ruby Freeman, Dejah Blake, Kiran Lakhani, Doris R. Powell, Sagar Lonial, Benjamin G. Barwick, Ajay K. Nooka, Sarwish Rafiq, Mala Shanmugam
Journal: Blood (2023)
Assessing Donor and Platelet Transfusion Characteristics on Intracranial Hemorrhage Outcomes
Authors: David Roh, Jonathan M Davis, Travis Lee, Patrick M Mitchell, Deborah Bookwalter, Elizabeth Stone, Matthew S. Karafin, Melissa M. Cushing, Bryan R Spencer, Roberta Bruhn, Jerome L. Gottschall, Alan E. Mast, Ritchard G. Cable, Steven Kleinman, Eldad A. Hod
Journal: Blood (2023)